ASHLEY FALLUCCA: Open Payments
NPI 1245531979 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 38 payments from 11 companies in 2025. Trend: 2023 $507 · 2024 $438 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $229 |
| AstraZeneca Pharmaceuticals LP | 9 | $154 |
| Lilly USA, LLC | 8 | $150 |
| ABBVIE INC. | 2 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Dexcom, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
Products named: Ozempic, MOUNJARO, AIRSUPRA, BREZTRI, ZORYVE, XIFAXAN, Wegovy, UBRELVY.
Industry payments across KS — which companies pay providers there.
